Evidence map›Paper›PMID 35145963›Full record

ArticleFrontiers in physics2021

Systems Biology Modeling of the Complement System Under Immune Susceptible Pathogens.

Nehemiah T Zewde, Rohaine V Hsu, Dimitrios Morikis, Giulia Palermo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Complement system in Anti-CD20 mAb therapy for cancer: A mini-review.International journal of immunopathology and pharmacology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nehemiah T ZewdeDepartment of Bioengineering, University of California, Riverside, Riverside, CA, United States.
Rohaine V HsuDepartment of Bioengineering, University of California, Riverside, Riverside, CA, United States.
Dimitrios MorikisDepartment of Bioengineering, University of California, Riverside, Riverside, CA, United States.
Giulia PalermoDepartment of Bioengineering, University of California, Riverside, Riverside, CA, United States.
University of California, Riverside · US

Funding

Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9R01GM141329 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI PALERMO, GIULIA · 2021 to 2025
$1.7M
Discovery of Biomarkers for Age-Related Macular DegenerationR01EY027440 · NEI · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI VULLEV, VALENTINE · 2017 to 2020
$1.5M
NEI NIH HHS R01 EY027440NIGMS NIH HHS R01 GM141329
6 · The paper itself

Abstract

The complement system is assembled from a network of proteins that function to bring about the first line of defense of the body against invading pathogens. However, complement deficiencies or invasive pathogens can hijack complement to subsequently increase susceptibility of the body to infections. Moreover, invasive pathogens are increasingly becoming resistant to the currently available therapies. Hence, it is important to gain insights into the highly dynamic interaction between complement and invading microbes in the frontlines of immunity. Here, we developed a mathematical model of the complement system composed of 670 ordinary differential equations with 328 kinetic parameters, which describes all three complement pathways (alternative, classical, and lectin) and includes description of mannose-binding lectin, collectins, ficolins, factor H-related proteins, immunoglobulin M, and pentraxins. Additionally, we incorporate two pathogens: (type 1) complement susceptible pathogen and (type 2)

Indexed as

complement systemcomputational systems biologyNeisseria meningitidispredictive modelingpredictive network biologyprotein network

Identifiers

PMID35145963
PMCPMC8827490
OpenAlexW3158719564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.